These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 20237834)
1. The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells. Shi M; Liu D; Duan H; Qian L; Wang L; Niu L; Zhang H; Yong Z; Gong Z; Song L; Yu M; Hu M; Xia Q; Shen B; Guo N Breast Cancer Res Treat; 2011 Jan; 125(2):351-62. PubMed ID: 20237834 [TBL] [Abstract][Full Text] [Related]
2. Catecholamine-Induced β2-adrenergic receptor activation mediates desensitization of gastric cancer cells to trastuzumab by upregulating MUC4 expression. Shi M; Yang Z; Hu M; Liu D; Hu Y; Qian L; Zhang W; Chen H; Guo L; Yu M; Song L; Ma Y; Guo N J Immunol; 2013 Jun; 190(11):5600-8. PubMed ID: 23630346 [TBL] [Abstract][Full Text] [Related]
3. HER2-dependent MMP-7 expression is mediated by activated STAT3. Yuan G; Qian L; Shi M; Lu F; Li D; Hu M; Yu M; Shen B; Guo N Cell Signal; 2008 Jul; 20(7):1284-91. PubMed ID: 18411043 [TBL] [Abstract][Full Text] [Related]
4. A novel cis-acting element in Her2 promoter regulated by Stat3 in mammary cancer cells. Qian L; Chen L; Shi M; Yu M; Jin B; Hu M; Xia Q; Zhang X; Shen B; Guo N Biochem Biophys Res Commun; 2006 Jun; 345(2):660-8. PubMed ID: 16696944 [TBL] [Abstract][Full Text] [Related]
5. A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer. Liu D; Deng Q; Sun L; Wang T; Yang Z; Chen H; Guo L; Liu Y; Ma Y; Guo N; Shi M BMC Cancer; 2015 Nov; 15():832. PubMed ID: 26526356 [TBL] [Abstract][Full Text] [Related]
6. Human epidermal growth factor receptor 2 regulates angiopoietin-2 expression in breast cancer via AKT and mitogen-activated protein kinase pathways. Niu G; Carter WB Cancer Res; 2007 Feb; 67(4):1487-93. PubMed ID: 17308086 [TBL] [Abstract][Full Text] [Related]
7. β2-AR signaling controls trastuzumab resistance-dependent pathway. Liu D; Yang Z; Wang T; Yang Z; Chen H; Hu Y; Hu C; Guo L; Deng Q; Liu Y; Yu M; Shi M; Du N; Guo N Oncogene; 2016 Jan; 35(1):47-58. PubMed ID: 25798840 [TBL] [Abstract][Full Text] [Related]
8. TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer. Helms MW; Kemming D; Contag CH; Pospisil H; Bartkowiak K; Wang A; Chang SY; Buerger H; Brandt BH Cancer Res; 2009 Jun; 69(12):5049-56. PubMed ID: 19491269 [TBL] [Abstract][Full Text] [Related]
9. Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1. Lattrich C; Juhasz-Boess I; Ortmann O; Treeck O Oncol Rep; 2008 Mar; 19(3):811-7. PubMed ID: 18288420 [TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha. Weitsman GE; Weebadda W; Ung K; Murphy LC Breast Cancer Res Treat; 2009 Nov; 118(2):269-79. PubMed ID: 18941890 [TBL] [Abstract][Full Text] [Related]
11. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells. Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183 [TBL] [Abstract][Full Text] [Related]
12. β2-AR activation promotes cleavage and nuclear translocation of Her2 and metastatic potential of cancer cells. Liu D; Zha L; Liu Y; Zhao X; Xu X; Liu S; Ma W; Zheng J; Shi M Cancer Sci; 2020 Dec; 111(12):4417-4428. PubMed ID: 33016509 [TBL] [Abstract][Full Text] [Related]
13. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors. Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219 [TBL] [Abstract][Full Text] [Related]
14. A negative feedback regulatory loop associates the tyrosine kinase receptor ERBB2 and the transcription factor GATA4 in breast cancer cells. Hua G; Zhu B; Rosa F; Deblon N; Adélaïde J; Kahn-Perlès B; Birnbaum D; Imbert J Mol Cancer Res; 2009 Mar; 7(3):402-14. PubMed ID: 19276186 [TBL] [Abstract][Full Text] [Related]
15. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation. Aigner A; Juhl H; Malerczyk C; Tkybusch A; Benz CC; Czubayko F Oncogene; 2001 Apr; 20(17):2101-11. PubMed ID: 11360194 [TBL] [Abstract][Full Text] [Related]
16. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Gritsko T; Williams A; Turkson J; Kaneko S; Bowman T; Huang M; Nam S; Eweis I; Diaz N; Sullivan D; Yoder S; Enkemann S; Eschrich S; Lee JH; Beam CA; Cheng J; Minton S; Muro-Cacho CA; Jove R Clin Cancer Res; 2006 Jan; 12(1):11-9. PubMed ID: 16397018 [TBL] [Abstract][Full Text] [Related]
17. HER2 regulatory control of angiopoietin-2 in breast cancer. Carter WB; Ward MD Surgery; 2000 Aug; 128(2):153-8. PubMed ID: 10922985 [TBL] [Abstract][Full Text] [Related]
18. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214 [TBL] [Abstract][Full Text] [Related]
19. An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells. Grunt TW; Puckmair K; Tomek K; Kainz B; Gaiger A Biochem Biophys Res Commun; 2005 Apr; 329(4):1253-9. PubMed ID: 15766561 [TBL] [Abstract][Full Text] [Related]
20. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Huang Y; Li X; Jiang J; Frank SJ Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]